338 related articles for article (PubMed ID: 30315413)
1. The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?
Ayhan A; Akilli H; Haberal N
Arch Gynecol Obstet; 2019 Jan; 299(1):217-222. PubMed ID: 30315413
[TBL] [Abstract][Full Text] [Related]
2. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
Ayhan A; Mao TL; Seckin T; Wu CH; Guan B; Ogawa H; Futagami M; Mizukami H; Yokoyama Y; Kurman RJ; Shih IeM
Int J Gynecol Cancer; 2012 Oct; 22(8):1310-5. PubMed ID: 22976498
[TBL] [Abstract][Full Text] [Related]
3. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
Cuff J; Longacre TA
Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
[TBL] [Abstract][Full Text] [Related]
4. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis.
Paik ES; Kim TJ; Choi CH; Kim BG; Bae DS; Lee JW
J Gynecol Oncol; 2018 Mar; 29(2):e18. PubMed ID: 29400011
[TBL] [Abstract][Full Text] [Related]
6. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
Soovares P; Pasanen A; Bützow R; Lassus H
Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
[TBL] [Abstract][Full Text] [Related]
7. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
Ju UC; Kang WD; Kim SM
Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
10. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study.
Scarfone G; Bergamini A; Noli S; Villa A; Cipriani S; Taccagni G; Vigano' P; Candiani M; Parazzini F; Mangili G
Gynecol Oncol; 2014 Jun; 133(3):480-4. PubMed ID: 24642093
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.
Davis M; Rauh-Hain JA; Andrade C; Boruta DM; Schorge JO; Horowitz NS; May T; del Carmen MG
Gynecol Oncol; 2014 Mar; 132(3):760-6. PubMed ID: 24440832
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
14. Histologic transformation of benign endometriosis to early epithelial ovarian cancer.
Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA
Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545
[TBL] [Abstract][Full Text] [Related]
15. Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis.
Barreta A; Sarian L; Ferracini AC; Eloy L; Brito ABC; de Angelo Andrade L; Derchain S
Int J Gynecol Cancer; 2018 Sep; 28(7):1251-1257. PubMed ID: 30142123
[TBL] [Abstract][Full Text] [Related]
16. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
Chew S; Tham KF; Ratnam SS
Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
[TBL] [Abstract][Full Text] [Related]
17. Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2018 Jan; 28(1):11-18. PubMed ID: 28930811
[TBL] [Abstract][Full Text] [Related]
18. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.
Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M
Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of the PTEN protein and matrix metalloproteinase-2 in endometrial cysts, endometrioid and clear cell ovarian cancer.
Brucka A; Szyłło K
Ginekol Pol; 2013 May; 84(5):344-51. PubMed ID: 23819399
[TBL] [Abstract][Full Text] [Related]
20. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
Zhan X; Li L; Wu M; Lang J
Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]